New Jersey-based pharmaceutical company Sanofi-aventis has agreed to acquire rival BiPar Sciences for an undisclosed sum
Related Topics
Venture capital funding
New Jersey-based pharmaceutical company Sanofi-aventis has agreed to acquire rival BiPar Sciences for an undisclosed sum